# Microbial tryptophan metabolism activates host lysosomal activity to facilitate lipid breakdown

**Authors:** Kenan Zhang, Zihan Luo, Yan Chen, Yan Li, Lang Wang, Yanan Liu, Ruizhi Yang, Qian Li, Jiahao Zhao, Bin Qi, Zhao Shan, Melissa Vazquez Hernandez, Melissa Vazquez Hernandez, Melissa Vazquez Hernandez, Melissa Vazquez Hernandez, Melissa Vazquez Hernandez

PMC · DOI: 10.1371/journal.pbio.3003685 · PLOS Biology · 2026-02-26

## TL;DR

This study shows how gut bacteria metabolize tryptophan to produce indole, which activates lysosomes in worms and human liver cells to break down lipids.

## Contribution

The novel finding is that microbial tryptophan metabolism, specifically via indole, activates lysosomal activity to enhance lipid breakdown in both C. elegans and mammalian cells.

## Key findings

- Bacterial tryptophan catabolism via TnaA induces lysosomal lipid chaperone LBP-8 to mobilize lipids in C. elegans.
- Indole, a tryptophan metabolite, enhances lysosomal acidification and degradation in mammalian hepatocytes.
- Lysosomal lipase activity promotes mitochondrial β-oxidation, and this pathway is conserved across species.

## Abstract

Lysosomes are central to lipid metabolism, yet how gut microbiota-derived metabolites regulate lysosomal function to influence host lipid homeostasis remains unknown. Here, we identify a mechanism in which bacterial tryptophan metabolism activates lysosomal activity to promote lipid breakdown in Caenorhabditis elegans, and show that the bacterial tryptophan metabolite indole recapitulates these effects in mammalian hepatocytes. By developing a lysosomal-responsive lipid reporter in C. elegans to screen for bacterial metabolic states that modulate host lipid storage, we discover that Escherichia coli tryptophan catabolism via tryptophanase TnaA induces lysosomal lipid chaperone LBP-8, driving lipid mobilization. Moreover, tryptophan metabolite indole enhanced lysosomal acidification and degradation capacity, while genetic disruption of lysosomal regulators reversed these effects. Strikingly, bacterial tryptophan metabolism further promoted mitochondrial β-oxidation through lysosomal lipase activity. This pathway was conserved in mammalian hepatocytes, where E. coli-derived tryptophan metabolite indole enhances lysosomal function and reduce lipid accumulation. Our work uncovers microbiota-regulated lysosomal activation as a critical axis in lipid homeostasis, highlighting its potential as a therapeutic target for metabolic disorders linked to lysosomal dysfunction.

Microbial derived metabolites are known to influence host physiology. This study expands the mechanistic understanding of this relationship, by showing that microbial production of indole from bacterial tryptophan catabolism enhances lysosomal acidification and lipase activity in a C. elegans host and in mammalian hepatocytes.

## Linked entities

- **Genes:** tnaA (tryptophanase) [NCBI Gene 915393], lbp-8 (Fatty acid-binding protein homolog 8) [NCBI Gene 188761]
- **Chemicals:** tryptophan (PubChem CID 1148), indole (PubChem CID 798)
- **Species:** Caenorhabditis elegans (taxon 6239), Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** CTSD (cathepsin D) [NCBI Gene 1509] {aka CLN10, CPSD, HEL-S-130P}, Ctsd (cathepsin D) [NCBI Gene 13033] {aka CD, CatD}, TDO2 (tryptophan 2,3-dioxygenase) [NCBI Gene 6999] {aka HYPTRP, TDO, TO, TPH2, TRPO}, lbp-8 (Fatty acid-binding protein homolog 8) [NCBI Gene 188761], LIPN (lipase family member N) [NCBI Gene 643418] {aka ARCI8, LI4, LIPL4, bA186O14.3}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, lipl-4 (Lipase lipl-4) [NCBI Gene 179046], Ctsb (cathepsin B) [NCBI Gene 13030] {aka APPM, CB}
- **Diseases:** NAFLD (MESH:D065626), ACDH (MESH:D054069), lysosomal dysfunction (MESH:D016464), metabolic syndrome (MESH:D024821), inflammation (MESH:D007249), neurodegenerative diseases (MESH:D019636), metabolic diseases (MESH:D008659), obesity (MESH:D009765), fatty liver disease (MESH:D005234), NGM (MESH:D009349), adiposity (MESH:D018205), type 2 diabetes (MESH:D003924)
- **Chemicals:** nitrogen (MESH:D009584), ammonium chloride (MESH:D000643), ammonium (MESH:D064751), tert-butyl hydroperoxide (MESH:D020122), oleoylethanolamine (MESH:C000707817), streptomycin (MESH:D013307), agar (MESH:D000362), TGs (MESH:D014280), fat (MESH:D005223), pyruvate (MESH:D019289), isopropanol (MESH:D019840), SDS (MESH:D012967), BafA1 (MESH:C040929), carbenicillin (MESH:D002228), BMP (MESH:C012786), kanamycin (MESH:D007612), cholesterol (MESH:D002784), water (MESH:D014867), phospholipid (MESH:D010743), ORO (MESH:C011049), TRIzol (MESH:C411644), LysoSensor Green DND-189 (MESH:C000604339), FFAs (MESH:D005230), amino acid (MESH:D000596), fatty acid (MESH:D005227), CEs (MESH:D002788), Abcam (-), hematoxylin (MESH:D006416), penicillin (MESH:D010406), glycerin (MESH:D005990), H (MESH:D006859), IAA (MESH:C030737), polyvinylidene fluoride (MESH:C024865), Trp (MESH:D014364), PBS (MESH:D007854), OA (MESH:D019301), ROS (MESH:D017382), levamisole (MESH:D007978), Indole (MESH:C030374), DMSO (MESH:D004121), IPTG (MESH:D007544), ATP (MESH:D000255), ampicillin (MESH:D000667), ammonium sulfate (MESH:D000645), agarose (MESH:D012685), CMXRos (MESH:C107472), PFA (MESH:C003043), Lipid (MESH:D008055), PA (MESH:D019308)
- **Species:** Caenorhabditis elegans (species) [taxon 6239], Mus musculus (house mouse, species) [taxon 10090], Stenotrophomonas (genus) [taxon 40323], Escherichia coli HT115 (strain) [taxon 634469], Escherichia coli OP50 (strain) [taxon 637912], Escherichia coli (E. coli, species) [taxon 562], Salmonella (genus) [taxon 590], C. elegans [taxon 328850], Enterococcus faecalis (species) [taxon 1351], Sphingomonas (genus) [taxon 13687], Mycobacterium tuberculosis (species) [taxon 1773], Vibrio cholerae (species) [taxon 666], Homo sapiens (human, species) [taxon 9606], Escherichia coli K-12 (strain) [taxon 83333], Rodentia (rodent, order) [taxon 9989], Nematoda (nematode, phylum) [taxon 6231], Ochrobactrum (genus) [taxon 528], Enterobacteriaceae (enterobacteria, family) [taxon 543], Shigella (genus) [taxon 620], Pseudomonas (RNA similarity group I, genus) [taxon 286]
- **Mutations:** tryptophan for 60, R3, C for 1-2, S3E
- **Cell lines:** HT115 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_2520), K12 — Felis catus (Cat), Feline mammary carcinoma, Cancer cell line (CVCL_IX41), -1::CHERRY — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_WJ50), -1::pHTomato — Mus musculus (Mouse), Hybridoma (CVCL_C7RB), YNU623 — Homo sapiens (Human), Adrenoleukodystrophy, Finite cell line (CVCL_JB78), YNU606 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_DQ11), OP50 — Homo sapiens (Human), q11.2) BCR-ABL1, Cancer cell line (CVCL_DG77), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), col — Homo sapiens (Human), Plasma cell myeloma, Cancer cell line (CVCL_A6IS), E. coli K-12 — Mus musculus (Mouse), Hybridoma (CVCL_C5CR), E. coli K-12 BW25113 — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_X356), HUH7 — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_0336), CL2166 — Homo sapiens (Human), Huntington's disease, Transformed cell line (CVCL_F054), B6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), XW19180 — Homo sapiens (Human), Obsessive compulsive disorder, Induced pluripotent stem cell (CVCL_VR56), YNU624 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_8054), Hub7 — Canis lupus familiaris (Dog), Canine mammary carcinoma, Cancer cell line (CVCL_C1IJ), NUC-1::CHERRY — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_2147)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956088/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956088/full.md

## References

52 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956088/full.md

---
Source: https://tomesphere.com/paper/PMC12956088